Search results for "RC666-701"

showing 10 items of 122 documents

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis

2021

Aims: Low plasma testosterone levels have been shown to predict worse outcome in men with severe atherosclerotic disease. We hypothesized that a low plasma testosterone level affects disease risk through changes in gene expression in atherosclerotic plaques. Therefore, we studied plasma testosterone levels in relation to gene expression levels in atherosclerotic plaque tissue of men with advanced atherosclerotic disease.Methods: Plasma testosterone levels were measured in 203 men undergoing carotid endarterectomy. The corresponding atherosclerotic plaque tissue was used for RNA sequencing. First, we assessed how often the androgen receptor gene was expressed in the plaque. Second, correlati…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmenttranscriptome (RNA-seq)menRNA-SeqEndogenyCarotid endarterectomyCardiovascular MedicineAndrogen receptorTranscriptomeEndocrinologyRC666-701Internal medicinetestosteroneGene expressionDiseases of the circulatory (Cardiovascular) systemMedicineatherosclerosisRNA-expressionCardiology and Cardiovascular MedicinebusinessGeneTestosteroneOriginal ResearchFrontiers in Cardiovascular Medicine
researchProduct

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrom…

2013

Thrombophilic genetic factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A were studied as risk factors in 235 Caucasian subjects: 85 patients with abdominal thrombosis (54 with portal vein thrombosis (PVT) and 31 with Budd-Chiari syndrome (BCS) without liver cirrhosis or hepatocellular carcinoma) and 150 blood bank donors. Seventy-five patients with PVT/BCS showed associated disease or particular clinical status (46 PVT/29 BCS): 37 myeloproliferative neoplasm (20 PVT/17 BCS), 12 abdominal surgery (10 PVT/2 BCS), 10 contraception or pregnancy (6 PVT/4 BCS), 7 abdominal acute disease (6 PVT/1 BCS), and 9 chronic disease (4 PVT/5 BCS); ten patients did not present any association …

medicine.medical_specialtyeducation.field_of_studyCirrhosisArticle Subjectbusiness.industryPopulationmedicine.diseaseGastroenterologyThrombosisPortal vein thrombosisSurgeryHepatocellular carcinomaInternal medicineRC666-701Budd–Chiari syndromemedicineClinical StudyDiseases of the circulatory (Cardiovascular) systemCardiology and Cardiovascular MedicinebusinesseducationMyeloproliferative neoplasmAbdominal surgeryInternational Journal of Vascular Medicine
researchProduct

Clot Composition Analysis as a Diagnostic Tool to Gain Insight into Ischemic Stroke Etiology: A Systematic Review

2021

Mechanical thrombectomy renders the occluding clot available for analysis. Insights into thrombus composition could help establish the stroke cause. We aimed to investigate the value of clot composition analysis as a complementary diagnostic tool in determining the etiology of large vessel occlusion (LVO) ischemic strokes (International Prospective Register of Systematic Reviews [PROSPERO] registration # CRD42020199436). Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we ran searches on Medline (using the PubMed interface) and Web of Science for studies reporting analyses of thrombi retrieved from LVO stroke patients subjected to mechani…

medicine.medical_specialtyetiologyMEDLINEReviewComposition analysiscerebral thrombusCerebral thrombus Etiology Ischemic stroke Systematic review ThrombectomyEmbolussystematic reviewischemic strokeMedicineDiseases of the circulatory (Cardiovascular) systemcardiovascular diseasesThrombusIntensive care medicineStrokebusiness.industrymedicine.diseaseSystematic reviewthrombectomyRC666-701EtiologyNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessCohort studyJournal of Stroke
researchProduct

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis

2021

Abstract Aims Cardiac resynchronization therapy (CRT) is highly effective in dilated cardiomyopathy (DCM) patients with impaired left ventricular ejection fraction (LVEF) and left bundle block branch. In cardiac amyloidosis (CA) patients, left ventricular dysfunction and conduction defects are common, but the potential of CRT to improve cardiac remodelling and survival in this particular setting remains undefined. We investigated cardiovascular outcomes in CA patients after CRT implantation in terms of CRT echocardiographic response and major cardiovascular events (MACEs). Methods and results Our retrospective study included 47 CA patients implanted with CRT devices from January 2012 to Feb…

medicine.medical_specialtygenetic structuresmedicine.medical_treatmentPopulationCardiac resynchronization therapyHeart failureCardiac amyloidosisVentricular Function LeftInternal medicineImplantable cardioverter defibrillatormedicineHumansDiseases of the circulatory (Cardiovascular) systemcardiovascular diseaseseducationAgedRetrospective StudiesAged 80 and overeducation.field_of_studyCardiac resynchronization therapyEjection fractionbusiness.industryHazard ratioDilated cardiomyopathyStroke VolumeOriginal ArticlesAmyloidosismedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantablePacemakerTreatment OutcomeCardiac amyloidosisHeart failureRC666-701Cardiologycardiovascular systemOriginal ArticleCardiology and Cardiovascular Medicinebusinesstherapeuticscirculatory and respiratory physiologyESC Heart Failure
researchProduct

Cardiovascular Implantable Electronic Device Infection and New Insights About Correlation Between Pro-inflammatory Markers and Heart Failure: A Syste…

2021

Introduction: Surgical approaches to treat patients with abnormal pro-inflammatory parameters remain controversial, and the debate on the correlation between hematological parameter alteration in cardiac implantable electronic device (CIED) infection and the increase in mortality continues.Methods: We performed a systematic review using the PubMed, Scopus, and Cochrane Library databases. Twenty-two articles from May 2007 to April 2020 were selected and divided according to the following topics: prevalence of microbes in patients with CIED infection; characteristics of patients with CIED infection; comparison between patients who underwent and did not undergo replantation after device extrac…

medicine.medical_specialtyheart failure030204 cardiovascular system & hematologyCochrane LibraryCardiovascular Medicine03 medical and health sciences0302 clinical medicineSettore MED/43 - Medicina LegaleWhite blood cellInternal medicineEpidemiologymedicineDiseases of the circulatory (Cardiovascular) systemrisk factors030212 general & internal medicineLeukocytosisCIED infectionbusiness.industrymicrobiologyRed blood cell distribution widthmedicine.diseaseinflammatory markersComorbiditymedicine.anatomical_structureHeart failureMeta-analysisRC666-701cardiac infection CED infimammatorySystematic Reviewmedicine.symptomCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Pr…

2021

Background: Serum uric acid predicts the onset and progression of kidney disease, and the occurrence of cardiovascular and all-cause mortality. Nevertheless, it is unclear which is the appropriate definition of hyperuricemia in presence of chronic kidney disease (CKD). Our goal was to study the independent impact of uric acid and CKD on mortality.Methods: We retrospectively investigated 21,963 patients from the URRAH study database. Hyperuricemia was defined on the basis of outcome specific cut-offs separately identified by ROC curves according to eGFR strata. The primary endpoints were cardiovascular and all-cause mortality.Results: After a mean follow-up of 9.8 year, there were 1,582 (7.2…

medicine.medical_specialtyhyperuricemiaCardiovascular Medicineurologic and male genital diseasesGastroenterologyalbuminuriachemistry.chemical_compoundcardiovascular mortalityInternal medicinemedicineeGFRDiseases of the circulatory (Cardiovascular) systemHyperuricemiaRisk factorOriginal Researchbusiness.industryIncidence (epidemiology)Confoundingalbuminuria; all-cause mortality; cardiovascular mortality; eGFR; hyperuricemiahyperuricemia eGFR albuminuria cardiovascular mortality all-cause mortalitymedicine.diseasechemistryQuartileRC666-701AlbuminuriaUric acidall-cause mortalitymedicine.symptomCardiology and Cardiovascular MedicinebusinessKidney disease
researchProduct

Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction

2020

Aims Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a distinct HF phenotype, but whether patients on this category fare worse, similarly, or better than those with HF with reduced EF (HFrEF) or preserved EF (HFpEF) in terms of rehospitalization risks over time remains unclear. Methods and results We prospectively included 2961 consecutive patients admitted for acute HF (AHF) in our institution. Of them, 158 patients died during the index admission, leaving the sample size to be 2803 patients. Patients were categorized according to their EF: HFrEF if EF ≤ 40% (n = 908, 32.4%); HFmrEF if EF = 41–49% (n = 449, 16.0%); and HFpEF if EF ≥ 50% (n = 1446, 51.6%). Covar…

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemHeart failure030204 cardiovascular system & hematologyRecurrent events03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineCause of DeathOriginal Research ArticlesmedicineHumansIn patient030212 general & internal medicineRegistriesOriginal Research ArticleHeart FailureEjection fractionbusiness.industryMorbidity riskIncidenceHeart failure with mid-range ejection fractionStroke VolumeHeart failure with mid‐range ejection fractionmedicine.diseasePrognosisConfidence intervalReadmissionslcsh:RC666-701Heart failureCardiologyCardiology and Cardiovascular Medicinebusiness
researchProduct

Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation

2020

Abstract Aims Mitral annuloplasty using the Carillon Mitral Contour System (CMCS) reduces secondary mitral regurgitation (SMR) and leads to reverse left ventricular remodelling. The aim of this study was to evaluate the effect of the CMCS on the mitral valve annulus (MA) and left atrial volume (LAV). Methods and results We retrospectively evaluated the data of all patients treated with the CMCS at our centre. Using transthoracic echocardiography, MA diameters were assessed by measuring the anterolateral to posteromedial extend (ALPM) and the anterior to posterior (AP) dimensions, respectively. Also, LAV and left ventricular end‐diastolic volume (LVEDV) were assessed. Patients were examined …

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemMitral Valve AnnuloplastyCarillon030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineLeft atrialOriginal Research ArticlesInternal medicinemedicineHumansMitral Valve AnnulusOriginal Research Article030212 general & internal medicineMitral AnnuloplastyRetrospective StudiesMitral regurgitationbusiness.industryRemodellingMitral Valve InsufficiencyAtrial Remodelingmedicine.diseaseMitral valve annuluslcsh:RC666-701Heart failureTranscatheterPMVRCardiologyMitral ValveCardiology and Cardiovascular MedicinebusinessLAVPaired AnalysisESC Heart Failure
researchProduct

The Female Sex Confers Different Prognosis in Heart Failure: Same Mortality but More Readmissions

2021

Introduction: Heart failure (HF) is a major cause of morbimortality both in men and women. Differences between sex in etiopathogenesis, response to treatment, and quality of care have been found in patients with HF. Females are usually under-represented in clinical trials and there is no solid evidence demonstrating the influence of sex in the prognostic of chronic HF. The primary objective of this study was to analyse the differences in mortality and probability of hospital readmission between males and females with HF. The secondary objective was to compare mortality and probability of hospital readmission by ejection fraction (reduced vs. preserved).Methods: Patients with decompensated H…

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemMultivariate analysisheart failuremorbidity030204 cardiovascular system & hematologyCardiovascular Medicinereadmissions03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineInternal medicinegenderMedicinesex030212 general & internal medicineOriginal ResearchHospital readmissionEjection fractionbusiness.industryFemale sexleft ventricular ejection fractionmedicine.diseaseResponse to treatmentmortalityClinical triallcsh:RC666-701Heart failureCardiologyCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects

2009

The distribution of the T29C TGFβ1 gene polymorphism was analyzed in 198 hypertensives with left ventricular hypertrophy (LVH) and in 235 hypertensives without LVH. Circulating TGFβ1 levels, procollagen type III levels, microalbuminuria, and left ventricular geometry and function were evaluated in all the hypertensives with LVH subgrouped according to T29C TGFβ1 gene polymorphism. Circulating TGFβ1 was evaluated by ELISA technique, procollagen type III by a specific radioimmunoassay, microalbuminuria by radioimmunoassay, and left ventricular geometry and function by echocardiography. All groups were comparable for gender, age, and sex. Regarding T29C TGFβ1 gene polymorphism, prevalence of T…

medicine.medical_specialtylcsh:Diseases of the circulatory (Cardiovascular) systemSettore MED/09 - Medicina InternaArticle SubjectLeft ventricular hypertrophyExcretionGene PolymorphismInternal medicineGenotypeInternal MedicinemedicineTransforming Growth Factor β1 T29C; Gene Polymorphism; Left Ventricular Geometry; Hypertensioncardiovascular diseasesTransforming Growth Factor β1 T29CEjection fractionbusiness.industryLeft Ventricular GeometryRadioimmunoassaymedicine.diseaseSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatricheSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologylcsh:RC666-701HypertensionMicroalbuminuriaGene polymorphismbusinessResearch ArticleTransforming growth factorInternational Journal of Hypertension
researchProduct